FDA and industry have agreed in principal to a new five-year user fee agreement for medical devices, and the $595 million agreed to is more than double the amount collected under the prior user fee agreement, which netted the agency less than $290 million. However, industry will get some bang for the buck thanks to FDA's agreement to measure device reviews by total elapsed time rather than just the number of days an application is on the agency's clock.